Bioscience Trading Down News Today

Twist Bioscience Co. (NASDAQ:TWST – Get Free Report)’s stock price fell 4.4% during mid-day trading on Tuesday . The stock traded as low as $27.90 and last traded at $27.95. 98,884 shares changed hands during mid-day trading, a decline of 89% from the average session volume of 907,806 shares. The stock had previously closed at […]

Twist Bioscience Co. (NASDAQ:TWST – Get Free Report) SVP Paula Green sold 600 shares of the company’s stock in a transaction on Wednesday, March 6th. The shares were sold at an average price of $37.43, for a total value of $22,458.00. Following the sale, the senior vice president now owns 92,850 shares of the company’s […]

Twist Bioscience (NASDAQ:TWST – Get Free Report) had its price target lifted by equities research analysts at Barclays from $30.00 to $45.00 in a note issued to investors on Thursday, Benzinga reports. The brokerage presently has an “overweight” rating on the stock. Barclays‘s target price suggests a potential upside of 39.41% from the stock’s previous […]

Daré Bioscience, Inc. (NASDAQ:DARE – Get Free Report) was the recipient of a large increase in short interest in December. As of December 15th, there was short interest totalling 979,200 shares, an increase of 76.8% from the November 30th total of 553,900 shares. Based on an average daily volume of 494,500 shares, the days-to-cover ratio […]

Harvard Bioscience, Inc. (NASDAQ:HBIO – Get Free Report) was the target of a significant growth in short interest in September. As of September 30th, there was short interest totalling 1,050,000 shares, a growth of 13.0% from the September 15th total of 928,900 shares. Currently, 2.7% of the shares of the stock are short sold. Based […]

Shares of Twist Bioscience Co. (NASDAQ:TWST – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the seven analysts that are presently covering the firm, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The average […]

Emerald Bioscience Inc. (OTCMKTS:EMBI – Get Free Report) shares hit a new 52-week high on Tuesday . The company traded as high as $4.20 and last traded at $4.05, with a volume of 2927 shares. The stock had previously closed at $3.93. Emerald Bioscience Trading Down 8.6 % The company has a current ratio of […]

ARK Investment Management LLC lessened its holdings in Twist Bioscience Co. (NASDAQ:TWST – Free Report) by 3.1% in the second quarter, HoldingsChannel.com reports. The firm owned 6,959,240 shares of the company’s stock after selling 219,872 shares during the period. Twist Bioscience accounts for approximately 0.9% of ARK Investment Management LLC’s investment portfolio, making the stock […]

StockNews.com began coverage on shares of Harvard Bioscience (NASDAQ:HBIO – Free Report) in a research report report published on Thursday. The firm issued a buy rating on the medical instruments supplier’s stock. A number of other research firms have also weighed in on HBIO. Benchmark increased their price objective on Harvard Bioscience from $4.00 to […]

HC Wainwright reissued their buy rating on shares of Daré Bioscience (NASDAQ:DARE – Free Report) in a report issued on Friday, Benzinga reports. They currently have a $7.00 price objective on the biotechnology company’s stock. HC Wainwright also issued estimates for Daré Bioscience’s Q1 2024 earnings at ($0.07) EPS, Q2 2024 earnings at $0.00 EPS, […]